{"entity":{"type":"insider","cik":"0001625184","url":"/insider/0001625184","json_url":"/insider/0001625184.json","name":"Schwartz Aharon","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2018-12-06","last":"2025-08-12","span_basis":"filed_date"},"name_variants":[{"name":"Schwartz Aharon","source":"filing","n_filings":4,"first_seen":"2018-12-06","last_seen":"2025-08-12"}],"transactions":[{"id":4558916,"accession":"0001415889-25-021494","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-021494","line_url":"/filing/0001415889-25-021494#line-1","is_derivative":false,"issuer_cik":"0001006281","issuer_name":"Protalix BioTherapeutics, Inc.","issuer_ticker":"PLX","issuer_name_source":null,"issuer_url":"/issuer/0001006281","owner_cik":"0001625184","owner_name":"Schwartz Aharon","owner_display_name":"Schwartz Aharon","owner_url":"/insider/0001625184","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":129000.0,"shares_display":"129,000","price_per_share":1.596,"price_display":"1.60","price_state":"stated","total_value":205884.0,"total_display":"205,884.00","total_whole":"205,884","shares_owned_after":303000.0,"shares_owned_after_display":"303,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-10","filed_date":"2025-08-12","scope":"insider"},{"id":8284981,"accession":"0001104659-23-001495","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-001495","line_url":"/filing/0001104659-23-001495#line-1","is_derivative":false,"issuer_cik":"0001006281","issuer_name":"Protalix BioTherapeutics, Inc.","issuer_ticker":"PLX","issuer_name_source":null,"issuer_url":"/issuer/0001006281","owner_cik":"0001625184","owner_name":"Schwartz Aharon","owner_display_name":"Schwartz Aharon","owner_url":"/insider/0001625184","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":110000.0,"shares_display":"110,000","price_per_share":1.4165,"price_display":"1.42","price_state":"stated","total_value":155815.0,"total_display":"155,815.00","total_whole":"155,815","shares_owned_after":174000.0,"shares_owned_after_display":"174,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"},{"id":3001999,"accession":"0001104659-20-045926","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-045926","line_url":"/filing/0001104659-20-045926#line-1","is_derivative":false,"issuer_cik":"0001006281","issuer_name":"Protalix BioTherapeutics, Inc.","issuer_ticker":"PLX","issuer_name_source":null,"issuer_url":"/issuer/0001006281","owner_cik":"0001625184","owner_name":"Schwartz Aharon","owner_display_name":"Schwartz Aharon","owner_url":"/insider/0001625184","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":64000.0,"shares_display":"64,000","price_per_share":2.426,"price_display":"2.43","price_state":"stated","total_value":155264.0,"total_display":"155,264.00","total_whole":"155,264","shares_owned_after":64000.0,"shares_owned_after_display":"64,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-07","filed_date":"2020-04-13","scope":"insider"},{"id":6750021,"accession":"0001178913-18-003093","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001178913-18-003093","line_url":"/filing/0001178913-18-003093#line-3","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001625184","owner_name":"Schwartz Aharon","owner_display_name":"Schwartz Aharon","owner_url":"/insider/0001625184","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12200.0,"shares_display":"12,200","price_per_share":3.883,"price_display":"3.88","price_state":"stated","total_value":47372.6,"total_display":"47,372.60","total_whole":"47,373","shares_owned_after":112200.0,"shares_owned_after_display":"112,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-28","filed_date":"2018-12-06","scope":"insider"},{"id":6750018,"accession":"0001178913-18-003093","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001178913-18-003093","line_url":"/filing/0001178913-18-003093#line-2","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001625184","owner_name":"Schwartz Aharon","owner_display_name":"Schwartz Aharon","owner_url":"/insider/0001625184","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":3.916,"price_display":"3.92","price_state":"stated","total_value":195800.0,"total_display":"195,800.00","total_whole":"195,800","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-27","filed_date":"2018-12-06","scope":"insider"},{"id":6750015,"accession":"0001178913-18-003093","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-18-003093","line_url":"/filing/0001178913-18-003093#line-1","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001625184","owner_name":"Schwartz Aharon","owner_display_name":"Schwartz Aharon","owner_url":"/insider/0001625184","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":3.892,"price_display":"3.89","price_state":"stated","total_value":194600.0,"total_display":"194,600.00","total_whole":"194,600","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-26","filed_date":"2018-12-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001006281","name":"Protalix BioTherapeutics, Inc.","url":"/issuer/0001006281","role":"Director","n_filings":3,"first_seen":"2020-04-13","last_seen":"2025-08-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001606645","name":"Foamix Pharmaceuticals Ltd.","url":"/issuer/0001606645","role":"Director","n_filings":1,"first_seen":"2018-12-06","last_seen":"2018-12-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001625184","retrieved_at":"2026-08-24T21:22:48+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}